Responding to a Canadian study revealing osteoporosis drug Denosumab could have a protective effect against breast cancer for post-menopausal women,...

24 October 2018

Responding to a Danish study revealing statins could lower risk of breast cancer in the opposite breast, Grete Brauten-Smith, Clinical Nurse...

24 October 2018

The trial tested the benefit of adding palbociclib to fulvestrant in 521 women with advanced, hormone positive, HER2 negative breast cancer. While...

22 October 2018

Responding to Theresa May’s aim to increase early detection of cancer as outlined at the Conservative Party Conference on Wednesday 3 October,...

4 October 2018

Responding to new projections about the number of women dying from breast cancer in the UK, Samia al Qadhi, Chief Executive of Breast Cancer Care,...

28 September 2018

Mia Rosenblatt, Assistant Director of Policy and Campaigns at Breast Cancer Now, said: It’s incredibly worrying that, despite a recent review,...

24 September 2018

Responding to NHS England’s Cancer Waiting Times for July 2018, Gunes Kalkan, Head of Evidence, Policy and Campaigns at Breast Cancer Care,...

13 September 2018

Responding to an announcement from Jeane Freeman MSP, Health Secretary, revealing that 1,761 women aged over 71 in Scotland were not invited for...

13 September 2018

Responding to a new online tool that could better predict the long-term risk of oestrogen receptor positive breast cancer returning and the need for...

24 August 2018